SCHEMBL945501

SCHEMBL945501

CSC1=NC(c2cccc(Br)c2)(C2CCCCC2)N=C1N

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 15/20 0.47
KCNH2 Q12809 4/20 0.47
BACE2 Q9Y5Z0 6/20 0.38
CTSD P07339 3/20 0.36
APP P05067 1/20 0.34
CTSE P14091 1/20 0.31
HTR1A P08908 1/20 0.31
HTR1D P28221 1/20 0.31
HTR2A P28223 1/20 0.31
HTR2C P28335 1/20 0.31
HTR7 P34969 1/20 0.31
HTR2B P41595 1/20 0.31
HTR5A P47898 1/20 0.31
HTR6 P50406 1/20 0.31
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL931802 0.89 BACE1 (0.38) BACE1KCNH2BACE2CTSDHTR1A
SCHEMBL946218 0.88 BACE1 (0.49) BACE1KCNH2BACE2CTSDAPP
SCHEMBL932745 0.85 BACE1 (0.37) BACE1KCNH2BACE2CTSD
SCHEMBL932626 0.84 BACE1 (0.65) BACE1KCNH2BACE2CTSDAPP
SCHEMBL931210 0.81 BACE1 (0.47) BACE1KCNH2BACE2CTSDAPP
SCHEMBL931281 0.80 BACE1 (0.60) BACE1KCNH2BACE2CTSDAPP
SCHEMBL932230 0.77 BACE1 (0.59) BACE1KCNH2BACE2APP
SCHEMBL931852 0.70 BACE1 (0.49) BACE1KCNH2BACE2CTSD
SCHEMBL946784 0.70 BACE1 (0.76) BACE1KCNH2BACE2
SCHEMBL946602 0.69 BACE1 (0.57) BACE1KCNH2BACE2APPMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011002408-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed
WO-2011002408-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed